DURHAM, NC – January 11, 2016 – Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Bill Hawkins, retired Chairman and CEO of Medtronic and currently Lead Director of Immucor...

HOOFDDORP, THE NETHERLANDS – January 4, 2016 – Bioventus, a leader in orthobiologic solutions, today announced its entry into the patient care market in Taiwan with the launch of DUROLANE®, a single-injection...

DURHAM, NC – October 12, 2015 – Bioventus, a global leader in orthobiologics, today announced the launch of SUPARTZ FX™, a broadening of its current hyaluronic acid (HA) offering. SUPARTZ FX has an expanded label allowing for repeat injection cycles to help knee osteoarthritis (OA)